Literature DB >> 21615353

The role of IL-15 in central nervous system disorders.

M Rentzos1, A Rombos.   

Abstract

IL-15 is a proinflammatory cytokine. It is produced by activated blood monocytes, macrophages, dendritic cells, and activated glial cells. It promotes T-cell proliferation, induction of cytolytic effector cells including natural killer and cytotoxic cells and stimulates B-cell to proliferate and secrete immunoglobulins. Little information is available on the exact role of IL-15 in the neurological diseases. Microglial cells are the main regulators of both innate and adaptive immune responses in the central nervous system (CNS). IL-15 may be involved in the inflammatory reactions and microglial activation of some common CNS disorders such as multiple sclerosis, Alzheimer's and Parkinson's disease, but its exact role in their pathogenesis is not clear.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615353     DOI: 10.1111/j.1600-0404.2011.01524.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

Review 1.  Innate immunity: actuating the gears of celiac disease pathogenesis.

Authors:  Sangman Michael Kim; Toufic Mayassi; Bana Jabri
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-11       Impact factor: 3.043

Review 2.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

Review 3.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

4.  Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; A Scott Winter; Meharvan Singh; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  IL-15: a central regulator of celiac disease immunopathology.

Authors:  Valérie Abadie; Bana Jabri
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

6.  The expression levels of CHI3L1 and IL15Rα correlate with TGM2 in duodenum biopsies of patients with celiac disease.

Authors:  Paola Catrogiovanni; Giuseppe Musumeci; Salvatore Giunta; Rosa Imbesi; Michelino Di Rosa
Journal:  Inflamm Res       Date:  2020-06-04       Impact factor: 6.986

Review 7.  Inflammatory Response in the CNS: Friend or Foe?

Authors:  Marta Sochocka; Breno Satler Diniz; Jerzy Leszek
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

8.  Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice.

Authors:  Nasibeh Khayer; Sayed-Amir Marashi; Mehdi Mirzaie; Fatemeh Goshadrou
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

9.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study.

Authors:  Andreas Pikwer; Markus Castegren; Sijal Namdar; Kaj Blennow; Henrik Zetterberg; Niklas Mattsson
Journal:  J Neuroinflammation       Date:  2017-09-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.